Phase II enzyme inducer / chemopreventive agent

This page covers all Phase II enzyme inducer / chemopreventive agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting NAD(P)H quinone oxidoreductase (NQO1), glutathione S-transferases (GSTs), NQO1, GST, Nrf2 pathway.

Targets

NAD(P)H quinone oxidoreductase (NQO1), glutathione S-transferases (GSTs) · NQO1, GST, Nrf2 pathway

Phase 3 pipeline (2)

• Oltipraz 2 (120mg) · PharmaKing · Oncology / Chemoprevention
  Oltipraz is an organosulfur compound that induces phase II detoxification enzymes and antioxidant pathways to protect cells from oxidative stress and carcinogenic damage.
• Oltipraz 1 (90mg) · PharmaKing · Oncology
  Oltipraz is an organosulfur compound that induces phase II detoxification enzymes and antioxidant pathways, enhancing cellular defense against oxidative stress and carcinogens.

Patent intelligence

• phase ii enzyme inducer patent landscape — aggregated cliff calendar, attackable patents, originator estates